The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Search

      
          View 
        
      Event
    
      2023 CPhI Worldwide
    
        Date:
        
            2023/10/24
                        to 2023/10/26
                      
        Location:
        Barcelona, Spain
      
          View 
        
      Event
    
      2023 CPhI North America
    
        Date:
        
            2023/04/25
                        to 2023/04/27
                      
        Location:
        Philadelphia, USA
      
          View 
        
      Event
    
      Webinar: ASDs by Spray Drying: Process Development & Scale-Up
    
        Date:
        
            2023/03/22
                      
        Location:
        online
      
          View 
        
      Event
    
      2022 CPhI Worldwide
    
        Date:
        
            2022/11/01
                        to 2022/11/03
                      
        Location:
        Frankfurt, Germany
      
      View

News / Mar 24, 2021
The Low Carbon PledgeBusiness Action on climate

      View

News / Jul 23, 2021
Hovione signs the COP26 manifest to stop climate changesBCSD Portugal, 23 July 2021

      View

Press Release / Mar 18, 2024
Hovione and GEA Strengthen Partnership to Advance Continuous Tableting TechnologyThe agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally

      View

Press Clipping / Mar 06, 2022
Hovione promotes Herbeaux to CEOC&EN, 6 March 2022

      View

Press Release / Mar 18, 2025
Hovione’s new campus in Seixal enters final stage of construction. Set to open in mid-2027Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.

      View

Press Release / Mar 17, 2021
Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmicShowing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction

Browser not supported

Search

Types

Press Room

Categories

2023 CPhI Worldwide

2023 CPhI North America

Webinar: ASDs by Spray Drying: Process Development & Scale-Up

2022 CPhI Worldwide

The Low Carbon Pledge

Hovione signs the COP26 manifest to stop climate changes

Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology

Hovione promotes Herbeaux to CEO

Hovione’s new campus in Seixal enters final stage of construction. Set to open in mid-2027

Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic